These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18625151)

  • 1. Insulin resistance, microalbuminuria, and chronic kidney disease.
    Sarafidis PA; Ruilope LM
    Curr Hypertens Rep; 2008 Aug; 10(4):249-51. PubMed ID: 18625151
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiometabolic syndrome and chronic kidney disease.
    Lastra G; Manrique C; McFarlane SI; Sowers JR
    Curr Diab Rep; 2006 Jun; 6(3):207-12. PubMed ID: 16898573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of albuminuria and the metabolic syndrome.
    Rowley K; O'Dea K; Best JD
    Curr Diab Rep; 2003 Feb; 3(1):80-6. PubMed ID: 12643150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria and chronic kidney disease in association with the metabolic syndrome.
    Ninomiya T; Kiyohara Y
    J Cardiometab Syndr; 2007; 2(2):104-7. PubMed ID: 17684460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of metabolic syndrome and insulin resistance with microalbuminuria in senior citizens of rural communities in Japan --the Tanno and Sobetsu study--].
    Tabeya T; Ohnishi H; Saitoh S; Akasaka H; Mitsumata K; Chiba M; Furugen M; Mori M; Shimamoto K
    Nihon Ronen Igakkai Zasshi; 2008 May; 45(3):302-7. PubMed ID: 18622115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria and proximal tubule remodeling in the cardiometabolic syndrome.
    Hayden MR; Chowdhury NA; Witte L; Sowers JR
    J Cardiometab Syndr; 2006; 1(2):107-14. PubMed ID: 17679822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin: good, bad, or just plain ugly?
    Costacou T; Orchard TJ
    Kidney Int; 2008 Sep; 74(5):549-51. PubMed ID: 18709022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor.
    Cerasola G; Cottone S; Mulè G
    J Hypertens; 2010 Dec; 28(12):2357-69. PubMed ID: 20842046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease.
    Moinuddin I; Leehey DJ
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria, cardiovascular autonomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus.
    Takahashi N; Anan F; Nakagawa M; Yufu K; Ooie T; Nawata T; Shigematsu S; Hara M; Saikawa T; Yoshimatsu H
    Metabolism; 2004 Oct; 53(10):1359-64. PubMed ID: 15375795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of metabolic syndrome on chronic kidney disease].
    Calò LA
    Minerva Med; 2006 Dec; 97(6):451-8. PubMed ID: 17213781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to abandon microalbuminuria?
    Ruggenenti P; Remuzzi G
    Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and insulin resistance as risk factors for chronic kidney disease.
    Whaley-Connell A; Pavey BS; Afroze A; Bakris GL
    J Cardiometab Syndr; 2006; 1(3):209-14; quiz 215-6. PubMed ID: 17679819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinaemia, insulin resistance, microalbuminuria and the risk of coronary heart disease.
    Yudkin JS
    Ann Med; 1996 Oct; 28(5):433-8. PubMed ID: 8949975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance.
    Vedovato M; Lepore G; Coracina A; Dodesini AR; Jori E; Tiengo A; Del Prato S; Trevisan R
    Diabetologia; 2004 Feb; 47(2):300-3. PubMed ID: 14704836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In addition to obesity and insulin resistance, microalbuminuria and diminished insulin secretion are linked with the metabolic syndrome in community-dwelling nondiabetic Taiwanese subjects.
    Yang YC; Wu JS; Lu FH; Chang WC; Wu CH; Chang CJ
    Diabetes Res Clin Pract; 2007 Apr; 76(1):102-10. PubMed ID: 16956689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group.
    Agewall S; Fagerberg B; Attvall S; Ljungman S; Urbanavicius V; Tengborn L; Wikstrand J
    J Intern Med; 1995 Feb; 237(2):195-203. PubMed ID: 7852923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria.
    Lorenzo C; Nath SD; Hanley AJ; Abboud HE; Haffner SM
    Clin J Am Soc Nephrol; 2008 May; 3(3):783-9. PubMed ID: 18322051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome and chronic kidney disease in U.S. adults.
    Chen J; Muntner P; Hamm LL; Jones DW; Batuman V; Fonseca V; Whelton PK; He J
    Ann Intern Med; 2004 Feb; 140(3):167-74. PubMed ID: 14757614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.